Filter
633
Filtered Results: 633
Text search:
servicios
de
sangre
Featured
Recommendations
39
New Publications
128
Language
Document type
No document type
281
Guidelines
186
Studies & Reports
63
Manuals
41
Strategic & Response Plan
26
Fact sheets
14
Training Material
12
Brochures
6
Infographics
2
Situation Updates
1
Online Courses
1
Countries / Regions
Paraguay
60
Latin America and the Carribbean
45
Argentina
36
Colombia
33
Venezuela
33
Bolivia
32
Peru
16
El Salvador
15
Chile
12
Ecuador
12
Global
10
Western and Central Europe
10
Spain
10
Senegal
9
Burkina Faso
9
Congo, Democratic Republic of
7
Central African Republic
6
India
6
Eastern Europe
5
Guatemala
5
Mexico
4
Guinea
4
Africa
4
Mali
4
Kenya
3
Benin
3
Cameroon
3
Côte d’Ivoire / Ivory Coast
3
South Africa
3
Nicaragua
3
Honduras
3
Ukraine
2
Haiti
2
Dominican Republic
2
Germany
2
Brazil
2
Madagascar
2
Sierra Leone
1
Togo
1
Rwanda
1
Nigeria
1
Canada
1
Estonia
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Armenia
1
Guinea-Bissau
1
West and Central Africa
1
Luxembourg
1
Uruguay
1
Belgium
1
France
1
East and Southern Africa
1
Uganda
1
Russia
1
Djibouti
1
Romania
1
Angola
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
304
Clinical Guidelines
58
Women & Child Health
31
Key Resources
19
Public Health
17
Pharmacy & Technologies
9
Capacity Building
8
Toolboxes
COVID-19
100
TB
81
NTDs
50
Mental Health
40
HIV
32
Rapid Response
25
AMR
18
Zika
15
Caregiver
12
Disability
11
Malaria
11
Refugee
9
Ebola & Marburg
9
Planetary Health
6
Pharmacy
6
Conflict
6
Social Ethics
4
Natural Hazards
3
Cholera
3
Global Health Education
3
Polio
1
10–11 May 2016, Catania, Italy
Rapid review and case studies from Member States
J of Pharm Policy and Pract 14, 27 (2021). https://doi.org/10.1186/s40545-021-00309-8
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
Circulating vaccine-derived poliovirus type 2 in Angola
Ebola virus disease in Democratic Republic of the Congo
Dengue fever in Côte d’Ivoire
Humanitarian crisis in north-east Nigeria.
A systematic review informing a radical transformation of health workforce development
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Как и руководство 2006 года, настоящий документ предназначен для специалистов,
занимающихся разработкой государственных программ по борьбе с туберкулезом, педиатр...
Mass population movements have accounted for the emergence of Chagas disease (CD) outside endemic regions,
including the European Union/European Economic Area (EU/EEA). The parasite responsible for causing CD,
Trypanosoma cruzi (T. cruzi), can be transmitted through substances of human origin (SoH...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Maternal mortality has fallen significantly in recent years, especially in countries that have emphasized the prevention of its main causes, such as hemorrhagic and infectious complications and hypertension , including in the Region of the Americas. In its final report on the Plan of Action to Accel...
Pollution and health: a progress update
recommended
The Lancet Planetary Health Published:May 17, 2022DOI:https://doi.org/10.1016/S2542-5196(22)00090-0
Every year pollution causes 9 million deaths—1 in every 6 deaths worldwide, according to a Lancet Commission on pollution and health.
While the number of deaths caused by household air pollution a...
Journal of The Association of Physicians of India, Vol. 63 November 2015,, pp.77-96
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
European Union Standards for Tuberculosis Care 2017 Estonian Version
